Spruce Biosciences Rallies on Oppenheimer Outperform Rating
By Sam Boughedda Investing.com — Spruce Biosciences Inc (NASDAQ:) shares rose 21% Friday after bullish commentary from Oppenheimer. Oppenheimer analyst Hartaj Singh ...
Tag: Oppenheimer
Buy These 2 Stocks Before They Jump Over 100%, Says Oppenheimer
What occurs when headwinds meet tailwinds? In meteorology, head-on collisions of reverse air lots offers delivery to thunderstorms; add some ...